drugset / Trial / NCT06014385
PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to assess the target occupancy (TO) of scopolamine at M1 Muscarinic Receptors in the brain after single I.V. doses of scopolamine, in healthy control subjects, using the radiotracer \[11C\]EMO (also known as \[11C\]LSN3172176).
Timeline
- Start
- 2025-03
- Primary completion
- 2025-07-01
- Completion
- 2025-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Scopolamine | Unknown | 2 ug/kg | Intravenous |
| Subject | Scopolamine | Unknown | 4 ug/kg | Intravenous |
Indications
No indication recorded.